chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a consumer concerned a 56 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced it was like the flu, and sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the it was like the flu and sick was not reported. This report was non-serious. This case, from the same reporter is linked to 20211265856 and 20220110630.
Chills; Body aches; Sweating; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Lot number: EW0170) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1; Lot: ER8733), for Covid-19 immunization. The following information was reported: CHILLS (non-serious) with onset Apr2021, outcome "unknown", described as "Chills"; PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "Body aches"; HYPERHIDROSIS (non-serious) with onset Apr2021, outcome "unknown", described as "Sweating".  Additional information: Patient experienced chills, body aches and sweating. No fever was experienced. Symptoms started about 14 hours after second vaccine dose. No symptoms were experienced after first dose.  No follow-up attempts are possible. No further information is expected.
Patient reported having a bug bite then getting the flu shot. He reported a rash beginning 2 days after the immunization. He was to urgent care twice. The first time he was given hydrocortisone cream and oral diphenhydramine. He presented to urgent care a week later and the rash had not gone away. He was given oral methylprednisolone to accompany the hydrocortisone cream and diphenhydramine.
Moderna COVID vaccine njection on 01/29/21.  On 02/04/21 onset of redness, itching, firmness/mild swelling, mild pain on touch around injection site developing into a 2 inch diameter circular red patch around injection site.   Itchy with mild pain on touch and firmness/mild swelling.  Today, on 2/07/2021, redness lessening and boundary line of redness less distinct.  Still feels firm and itchy.
Patient received Zostavax vaccine on Wednesday, 1/20/2010. She started experiencing a rash, slight swelling, redness, and change in texture (rough) at injection site (left arm) on Thursday 1/21/2010. Patient did not seek treatment since reaction was not severe and did not self medicate/treat to relieve symptoms. Today, 1/25/2010, patient states symptoms are improving and not bothersome.
I was diagnosed with guillain-barre syndrome. After receiving my vaccine 3/19/21 i started to feel tingling in my feet around 4/30/2019 that made my feet hurt to walk on. The tingling than started to turn into a numbness at the tips of my toes and traveled throughout the rest of my feet making then feel hard to walk on. After about a week the numbness started to travel up my legs causing a decreased sensation on my legs where i started to feel tingling  sensations. Once it was almost to my knee and had already been to two doctors that werent sure of a diagnosis i went to the er where they were able to diagnose and treat me.
allergic reaction - hives entire bodys swelling of face & hands; Epi & DPH;
Tingling and numbness of the upper and lower lip (left side) Narrative:  Patient stated she felt a slight tingling and numbness of left side of the lower and upper lip. Symptoms resolved after about 30 seconds post-vaccination.
Experienced flu like symptoms approx 4 hours after injection .  Symptoms included aching muscles , sore throat, itchy eyes and nausea.
1 of 3 pts vax devel inject site reactions which began 4-5 hrs following vax; arm was very painful, hot to the touch & erythema was approx 7" in diameter; tx w/Augmentin;
Vomited day following the vaccine, couldn't walk until the afternoon on the day following the vaccine.  Developed spots on ankles, writs, arms, breast, and stomach that itch. Patient contacted pharmacy and it was recommended to be evaluated by the doctor to rule out shingles. Dr has evaluated and said not shingles, however triamcinolone cream was ordered for topical use on the spots. Everything else has resolved except itchy spots.
Red, raised skin plaques on face scalp, neck, shoulders, arms, back of thighs, shin, top of feet. Cortisone cream to effected areas.
After applying bandage to injection sites on right arm, patient began to state the last one hurt (HPV). Patient's speech stopped and pupils became dilated with eyes fixed upwardly. Patient became pale. Patient was assisted to floor where she became rigid and arched back. Patient let out a few blowing, pursed-lip breaths followed by a lash forward and scream. Immediately after the scream patient was talking and asking what had happened. Skin remained warm and dry, pale. Pupils returned to normal. Cool compresses were applied. Cool water was sipped. Blood pressure and pulse within normal limits. Entire syncopal episode lasted less than 5 minutes.
Had low grade fever the evening of the shot. The next morning she woke up to find the lower portion of her tongue was swollen. It never progressed to anything life threatening. No other symptoms. Resolved by the evening. No medications taken.
This case was reported by a healthcare professional and described the occurrence of accidental overdose in a 5-year-old female subject who was vaccinated with HAVRIX 1440 (GlaxoSmithKline).  Concurrent vaccinations given on 16 July 2008 included INFANRIX, (GlaxoSmithKline); IPV, (Sanofi); MMR II, (Merck); and VARICELLA virus (Merck).  On 16 July 2008 at 11:30, the subject inadvertently received an adult dose of HAVRIX 1440 (unknown, left arm), instead of the intended 1st dose of pediatric HAVRIX.  This was considered to be an accidental overdose and a maladministration.  At the time of this report, the parents of the subject had not been contacted or notified.  Follow-up information received on 01 August 2008 indicated that the HAVRIX 1440 dose administered to the subject was given intramuscularly.  Concurrent IPV and Infanrix vaccine were also administered intramuscularly, MMR and VARICELLA vaccine were given subcutaneously.  Three days following administration of HAVRIX, on 19 July 2008, the subject was diagnosed with acute gastroenteritis.  The subject suffered from loose stools, anorexia, fever and headache.  The reporter felt that these events were possibly related to treatment with HAVRIX.  A day later, on 20 July 2008, the subject experienced right otitis externa with pain.  These events were not related to HAVRIX according to the reporter.  All events resolved by 21 July 2008.
Localized, itchy rash on both arms at the injection sites. Lanacaine prn for relief of itching.
Headache, Myalgia, Fever, fatigue, sore throat Narrative:
This spontaneous report was received from a physician refers to a patient of unknown age and gender. No medical history was reported. The patient received dose 1 of GARDASIL (lot #, expiry not reported) on 25-JAN-2013 and dose 2 of GARDASIL (lot #, expiry not reported) on 09-APR-2013. On 12-JUN-2013, the patient was vaccinated with dose 3 of GARDASIL (lot #, expiry not reported). No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
I am a healthy 41 year old woman, mother of three children, citizen, with no history of medical conditions. On January 15th, 2022, I received the Moderna booster vaccine (this was my third vaccination, I had previously received two Pfizer vaccinations in the summer of 2021). Immediately following the vaccination, I experienced, for the first time in my life, severe insomnia, sleep paralysis, hallucinations, and very vivid dreams. I have been battling these symptoms since January of this year. I have consistently, every night with no exception, multiple vivid dreams (in which I am sometimes fully aware I am lying in my bed while dreaming). I also consistently wake up every morning unrefreshed and tired, and experience excessive daytime sleepiness throughout the day. In summary, I haven't had a proper restorative night's sleep since receiving the Moderna vaccine.  The muscles around my left eye have begun to twitch recently (past 4 weeks) and partially squeeze my eye closed throughout the day. Needless to say, I am extremely suspicious that the Moderna vaccine caused this, since nothing else can explain this sudden onset of symptoms. I have never had any issues with my sleep before. I am very healthy, and have a wonderful life otherwise.
Information has been received from a physician concerning a 15 month old female who on 17-Mar-2005 was vaccinated with a dose of measles virus vaccine live (Endera-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot number 648661/0610P). On approximately 26-Mar-2005, nine days after vaccination the child developed a measles like rash and mild fever. At the time of this report no fever was present and the rash was resolving.  Additional information has been requested.
swollen eye; fever; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swollen eye) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (swollen eye) and PYREXIA (fever). At the time of the report, EYE SWELLING (swollen eye) and PYREXIA (fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information was not provided. As per source document, a follow-up conducted with consumer on 06-Jul-21, the outcome of all adverse events reported had been resolved. Reporter did not allow further contact: Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant information received, outcome of the events updated and patient denied for further follow up.
Rash on front torso, both arms, both legs, groin . Rash on legs severe to point of weeping and cellulitis
My arm has been sore, hurting and now the other arm hurting.; I start itching I still do itch.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 02Apr2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient arm has been sore, hurting and now the other arm hurting and started itching, the patient still does itching. The seriousness of the events was unspecified. The outcome of the event arm has been sore, hurting and now the other arm hurting was unknown while outcome of the event start itching, the patient still do itch was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a Registered Nurse refers to a 30 year old female patient. On 29-OCT-2013, the patient was vaccinated with an expired dose of M-M-R II (lot # 671552/1542AA, expiry: 30-SEP-2013), 0.5 ml, subcutaneously. On 29-OCT-2013, the patient experienced patient was administered an expired dose of M-M-R II. No adverse effect reported. Additional information has been requested.
really really itchy; anytime after you scratch or touch anywhere on the skin becomes red; anytime after you scratch or touch anywhere on the skin becomes welty; anytime after you scratch or touch anywhere on the skin becomes bumpy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (really really itchy), ERYTHEMA (anytime after you scratch or touch anywhere on the skin becomes red), URTICARIA (anytime after you scratch or touch anywhere on the skin becomes welty) and RASH (anytime after you scratch or touch anywhere on the skin becomes bumpy) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 017C21A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced PRURITUS (really really itchy), ERYTHEMA (anytime after you scratch or touch anywhere on the skin becomes red), URTICARIA (anytime after you scratch or touch anywhere on the skin becomes welty) and RASH (anytime after you scratch or touch anywhere on the skin becomes bumpy). The patient was treated with FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D) for Allergy, at an unspecified dose and frequency. At the time of the report, PRURITUS (really really itchy), ERYTHEMA (anytime after you scratch or touch anywhere on the skin becomes red), URTICARIA (anytime after you scratch or touch anywhere on the skin becomes welty) and RASH (anytime after you scratch or touch anywhere on the skin becomes bumpy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. The patient got the booster shot and got a reaction 10 days later. He got really really itchy, and anytime after he scratch or touch anywhere on the skin, it becomes red and bumpy and Welty. Patient was using allergy medication to help with it. As soon as he stopped taking the medication, it starts right back up. The reactions were still going on now.
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 14-DEC-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (rHA) (lot # L012479, expiry date 10-APR-2017, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
after my second vaccine I started having severe migraines approximate about 5 weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Primary Immunization complete), for Covid-19 Immunization. The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "after my second vaccine I started having severe migraines approximate about 5 weeks".  Additional information: Patient was inquiring who could he/she report a concern to with the vaccine, after second vaccine patient started having severe migraines approximate about 5 weeks after the vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pain in my mouth; chronic pain in my upper left arm; This spontaneous case was reported by a non-health professional and describes the occurrence of ORAL PAIN (pain in my mouth) and PAIN (chronic pain in my upper left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Lactose intolerance, Gluten intolerance, Chronic fatigue (increasing with age but more so post COVID vaccine.), Fibromyalgia (increasing with age but more so post COVID vaccine.) and Oral pain. Concomitant products included VITAMIN D [VITAMIN D NOS] for Antiviral treatment, HYDROCORTISONE from 05-Jul-2020 to an unknown date for Fatigue, LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) and LEVOTHYROXINE from 06-Jun-2021 to an unknown date for Hypothyroidism, NALTREXONE from 02-Dec-2020 to an unknown date for Inflammation.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ORAL PAIN (pain in my mouth) and PAIN (chronic pain in my upper left arm). At the time of the report, ORAL PAIN (pain in my mouth) and PAIN (chronic pain in my upper left arm) outcome was unknown.            No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow-up received and added reporter details, other relevant history, concomitant medications and new event, vaccine facility information, dose dates,
A report was received from a health care professional on 27 October 2003 concerning approximately 100 vaccinees who inadvertently received Fluvirin vaccine subcutaneously during the week of 20 October 2003. During the week of 20 October 2003, approximately 100 vaccinees were administered Fluvirin subcutaneously. No adverse effects were reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Initial unsolicited report was received on 09 March 2015 from a consumer from a media report on the Internet. The reporter also reported another event which is captured in case number 2015SA031442. A female patient, age and date of birth not reported was vaccinated on an unreported date with Influenza vaccine, manufacturer, batch, site and route not reported.  On an unreported date she suffered a shoulder injury and "really can't move her arm". The patient reported that she needed surgery to fix the damage to her shoulder. The patient's medical history, concomitant medications and laboratory tests were not reported. The patient outcome is not recovered. No further details were available at the time of this report. Documents held by sender: None.
Two weeks after vaccine had lymph node on neck (left side) swollen and a cold sore on mouth (left).
tingling; numbing; diarrhea; feel the liquid squirting into my arm which is unusual; Fainted; nauseous; Memory lapse upon waking up; Breathing was slow; hot; sweaty; Arm pain; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EW0158), via an unspecified route of administration, administered in the left arm on 09Apr2021 at 10:30 AM at the age of 32-years-old as single dose for COVID-19 immunization. Vaccine facility type was reported as "Other". The patient had no COVID prior vaccination. The patient was not pregnant. The patient had no medical history and no known allergies. There were no concomitant medications. The patient had no other vaccine in four weeks and had no other medications in two weeks. On 09Apr2021, the patient fainted within 2 minutes if receiving vaccine. The patient had memory lapse upon waking up. Her breathing was slow. The patient was extremely nauseous, hot, sweaty. The patient was unable to sit up due to nausea for 1 hour. The following 2 days, the patient experienced nausea and diarrhea. Arm pain lasted for 7 days including tingling/numbing sensation down her entire arm on the 4th day (13Apr2021). At time of vaccine (09Apr2021 at 10:30 AM), she could feel the liquid squirting into her arm which was unusual. The patient reported that she gets lots of vaccines for traveling and have never had these reactions or sensations. The patient has not been tested for COVID post vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures (unspecified) were taken as a result of the events. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sore arm, headache, nausea, indigestion, fatigue, fever, weakness. Self treatment - tylenol. Symptoms started same night, about 10 hours after the injection. Lasted 2 days so far
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date the patient was vaccinated with PROQUAD (Merck) (lot number K003821, expiry date 17-SEP-2015) (lot number K007452, expiry date 21-NOV-2014) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse event was reported. The action taken with the therapy with PROQUAD (Merck) was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with PROQUAD (Merck) was unknown. There was no product quality issue reported. This case is linked to case number 1505USA001724 via same reporter link. Additional information has been requested.
I became very dizzy, extremely short of breath, had intense diarrhea, very clammy, and disoriented.
Sick; Initial information received on 28-Nov-2021 regarding an unsolicited valid non-serious case received from a consumer non health care professional (under reference number: US-SA-SAC20211201000485).  This case involves an unknown age and unknown gender patient who experienced sick (illness) after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiry date not reported via unknown route in unknown administration site.  On an unknown date the patient developed a non-serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/ event.  It was unknown if there were lab data/results available  At time of reporting, the outcome of the event was reported as unknown
Angioedema, ErythemaMultiform, Employee reported on inhalation at the right upper lung lobe Narrative: Employee reported redness and swelling at the vaccination area. She also reported mild to moderated pain at the right upper lung lobe which occurs during inhalation.